dc.contributor.author | Adewole, I.F. | |
dc.contributor.author | Abauleth, Y.R. | |
dc.contributor.author | Adoubi, I. | |
dc.contributor.author | Amorissani, F. | |
dc.contributor.author | Anorlu, R.I. | |
dc.contributor.author | Awolude, O.A. | |
dc.contributor.author | Botha, H. | |
dc.contributor.author | Byamugisha, J.K. | |
dc.contributor.author | Cisse, L. | |
dc.contributor.author | Diop, M. | |
dc.contributor.author | Doh, S. | |
dc.contributor.author | Fabamwo, A.O. | |
dc.contributor.author | Gahouma, D. | |
dc.contributor.author | Galadanci, H.S. | |
dc.contributor.author | Githanga, D. | |
dc.contributor.author | Magure, T.M. | |
dc.contributor.author | Mabogunje, C. | |
dc.contributor.author | Mbuthia, J. | |
dc.contributor.author | Muchiri, L.w. | |
dc.contributor.author | Ndiaye, O. | |
dc.contributor.author | Nyakabau, A.M. | |
dc.contributor.author | Ojwang, S.B.O. | |
dc.contributor.author | Ramogola-Masire, D. | |
dc.contributor.author | Sekyere, O. | |
dc.contributor.author | Smith, T.H. | |
dc.contributor.author | Taulo, F.O.G. | |
dc.contributor.author | Wewege, A. | |
dc.contributor.author | Wiredu, E. | |
dc.contributor.author | Yarosh, O. | |
dc.date.accessioned | 2021-10-07T11:26:58Z | |
dc.date.available | 2021-10-07T11:26:58Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Adewole, I.F. et al (2013) Consensus recommendations for the prevention of cervical cancer in sub-Saharan Africa, South African Journal of Gynaecological Oncology, Vol. 5, No. 2, pp. 47-57 | en_US |
dc.identifier.issn | 2074-2835 (electronic) | |
dc.identifier.uri | http://hdl.handle.net/10311/2181 | |
dc.description | Editorial assistance was provided by Dr Ian Seymour and Dr Tim Blackstock from Wells Healthcare Communications, funded with support from GSK. The authors take full responsibility for the content of this manuscript. | en_US |
dc.description.abstract | Cervical cancer is the second most common cancer and the leading cause of cancer-related death in women in
sub-Saharan Africa. It is estimated that more than 200 million females older than 15 years are at risk in this region. This paper highlights the current burden of cervical cancer in sub-Saharan Africa, reviews the latest clinical data on primary prevention, outlines challenges in the region, and offers potential solutions to these barriers. Based on these factors, clinical recommendations for the prevention of cervical cancer from the sub-Saharan African Cervical Cancer Working Group expert panel are presented. | en_US |
dc.description.sponsorship | The preparation of this report was supported by an educational grant from GlaxoSmithKline (GSK). | en_US |
dc.language.iso | en | en_US |
dc.publisher | MedPharm Publications (Medical Pharmaceutical Publishers), http://www.sajgo.co.za/ | en_US |
dc.subject | Africa | en_US |
dc.subject | Cervical cancer | en_US |
dc.subject | CC | en_US |
dc.subject | Human papillomavirus | en_US |
dc.subject | HPV | en_US |
dc.subject | Prevention | en_US |
dc.subject | Recommendations | en_US |
dc.subject | Screening | en_US |
dc.subject | Vaccination | en_US |
dc.title | Consensus recommendations for the prevention of cervical cancer in sub-Saharan Africa | en_US |
dc.type | Published Article | en_US |
dc.rights.holder | Publishers - MedPharm Publications and South African Society of Gynaecologic Oncology | en_US |
dc.link | http://www.sajgo.co.za/index.php/sajgo/article/view/135 | en_US |